Skip to main content
. 2022 Apr 13;13(5):1774–1786. doi: 10.1093/advances/nmac042

TABLE 1.

Detailed description of inclusion criteria1

Population Generally healthy participants (children, adolescents, and adults)
Intervention/exposure
  1. Dietary pattern: e.g., Mediterranean diet, Dietary Approaches to Stop Hypertension, low-carbohydrate diet.

  2. Food groups: the following food groups (macro-level) and foods (micro-level), e.g., grains, vegetables, fruit, milk and dairy products, meat, processed meat, fish, eggs, nuts, chocolate, oils, were considered.

  3. Macronutrients: carbohydrate (starch, fructose, glucose, sucrose); fat: e.g., ω-3 fatty acids (EPA, DHA, α-linolenic acid), ω-6 fatty acids (linoleic acid), monounsaturated fat; protein (e.g., amino acids).

  4. Micronutrients: vitamins: β-carotene; vitamins A, E, C (ascorbic acid), and D (cholecalciferol, ergocalciferol); B vitamins (thiamin, riboflavin, niacin, pyridoxine, cobalamin, folic acid). Minerals: magnesium, calcium, selenium, sodium, potassium, iron, zinc, copper, iodine.

  5. Other: fiber (psyllium, inulin, cellulose); probiotics; prebiotics; and synbiotics.

Control/comparison
  1. Low (no) intake (status) level of the foregoing interventions/exposure.

  2. Placebo/usual care.

Outcomes e.g. all-cause mortality, cardiovascular disease, ischemic heart disease (myocardial infarction, ischemic heart disease, and acute coronary syndrome), stroke, cancer, type 2 diabetes, dementia, fractures, age-related macular degeneration, anthropometric outcomes; important intermediate disease markers such as systolic blood pressure, diastolic blood pressure, fasting glucose, and LDL cholesterol.
Study design
  1. Systematic reviews of randomized controlled trials.

  2. Matching systematic reviews of CSs: CSs (if available, prospective CSs were preferred).

1

CS, cohort study.